Literature DB >> 6085226

Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.

P A Neighbour.   

Abstract

Peripheral blood lymphocytes from patients with multiple sclerosis (MS) have been shown by numerous investigators to function abnormally in a variety of immunological tests in vitro. In this article, data concerning defective natural killer (NK) cell function and interferon production by MS patients' lymphocytes have been reviewed. Production of IFN-alpha and IFN-gamma by appropriately stimulated lymphocytes has been shown to be significantly reduced in many patients with acute remitting or chronic progressive disease. Furthermore, a significant proportion of these patients has been found to exhibit reduced levels of endogenous and augmented NK cell activity. A likely explanation for these phenomena is that altered traffic occurring as a consequence of disease has led to a relative loss of NK and IFN-producing cells from the peripheral circulation. Flow cytometric data obtained using monoclonal antibodies that selectively label these effector populations were presented. Possible explanations for the observed defects and their significance relative to our understanding of the etiopathogenesis of MS were discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085226     DOI: 10.1111/j.1749-6632.1984.tb14789.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results.

Authors:  C Milanese; A Salmaggi; L La Mantia; A Campi; M Eoli; M Savoiardo; G Bianchi; A Nespolo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-07       Impact factor: 10.154

Review 3.  Interferons in relapsing-remitting multiple sclerosis: are there benefits from long-term use?

Authors:  Oscar Fernández
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 4.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.